HBW Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Buy |
+8,712
| New | +$211K | 0.03% | 382 |
|
|
2024
Q4 | – | Sell |
-10,542
| Closed | -$305K | – | 399 |
|
|
2024
Q3 | $305K | Buy |
10,542
+258
| +3% | +$7.47K | 0.04% | 275 |
|
|
2024
Q2 | $288K | Buy |
10,284
+2,893
| +39% | +$80.9K | 0.05% | 264 |
|
|
2024
Q1 | $213K | Hold |
7,391
| – | – | 0.04% | 281 |
|
|
2023
Q4 | $213K | Sell |
7,391
-8,478
| -53% | -$244K | 0.04% | 281 |
|
|
2023
Q3 | $526K | Sell |
15,869
-532
| -3% | -$17.6K | 0.11% | 171 |
|
|
2023
Q2 | $602K | Buy |
16,401
+1,795
| +12% | +$65.9K | 0.13% | 164 |
|
|
2023
Q1 | $596K | Sell |
14,606
-832
| -5% | -$34K | 0.15% | 154 |
|
|
2022
Q4 | $791K | Buy |
15,438
+190
| +1% | +$9.74K | 0.21% | 122 |
|
|
2022
Q3 | $668K | Buy |
15,248
+3,851
| +34% | +$169K | 0.19% | 139 |
|
|
2022
Q2 | $598K | Sell |
11,397
-2,017
| -15% | -$106K | 0.15% | 137 |
|
|
2022
Q1 | $694K | Sell |
13,414
-5,705
| -30% | -$295K | 0.24% | 106 |
|
|
2021
Q4 | $1.13M | Buy |
19,119
+640
| +3% | +$37.8K | 0.26% | 92 |
|
|
2021
Q3 | $794K | Buy |
18,479
+1,879
| +11% | +$80.7K | 0.21% | 121 |
|
|
2021
Q2 | $650K | Buy |
16,600
+5,918
| +55% | +$232K | 0.17% | 129 |
|
|
2021
Q1 | $387K | Buy |
10,682
+4,030
| +61% | +$146K | 0.1% | 163 |
|
|
2020
Q4 | $245K | Buy |
6,652
+261
| +4% | +$9.61K | 0.07% | 189 |
|
|
2020
Q3 | $223K | Buy |
+6,391
| New | +$223K | 0.09% | 171 |
|